Related Experiment Video

Updated: Aug 15, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Therapy insight: Management of hepatitis C in patients coinfected with HIV

Mark S Sulkowski1

  • 1Viral Hepatitis Center, Johns Hopkins Medical Institutions, Baltimore, MD 21287-0003, USA. msulkows@jhmi.edu

Nature Clinical Practice. Gastroenterology & Hepatology
|November 3, 2005
PubMed

Insights

Hepatitis C (HCV) treatment with peginterferon and ribavirin is safe and effective for HIV-infected patients. Multidisciplinary programs are crucial for improving care and outcomes in this complex patient population.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) coinfection is prevalent in human immunodeficiency virus (HIV)-infected individuals.
  • Managing HCV in HIV patients presents challenges due to immune suppression, drug interactions, and limited specialized care.
  • Effective treatment options for HCV in HIV patients are increasingly available.

Purpose of the Study:

  • To review the current management strategies for HCV infection in HIV-infected patients.
  • To highlight the safety, tolerability, and efficacy of available HCV treatments.
  • To emphasize the need for integrated, multidisciplinary care models.

Main Methods:

  • Review of existing clinical data and treatment guidelines.
  • Analysis of safety and efficacy of peginterferon plus ribavirin therapy.
  • Discussion of challenges in co-infected patient management.

Main Results:

  • Peginterferon plus ribavirin demonstrates safety, tolerability, and efficacy in treating HCV in HIV patients.
  • Standard of care for HCV treatment in this population is becoming clearer.
  • Care delivery for HCV remains inconsistent across different healthcare settings.

Conclusions:

  • HCV treatment is strongly indicated for HIV-infected patients.
  • Multidisciplinary programs involving HIV specialists, hepatologists, and other experts are essential.
  • Implementing these programs can improve HCV treatment outcomes in coinfected individuals.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...